Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisha Verma

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|September 15, 2022
Detrimental <i>NFKB1</i> missense variants affecting the Rel-homology domain of p105/p50Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, et al.
Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency DisordersJohn R Hurst, Nisha Verma, David Lowe, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Frontiers in Immunology|September 15, 2022
Detrimental <i>NFKB1</i> missense variants affecting the Rel-homology domain of p105/p50Manfred Fliegauf, Matias Kinnunen, Sara Posadas-Cantera, et al.
Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency DisordersJohn R Hurst, Nisha Verma, David Lowe, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 7